Publication | Closed Access

Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

Advanced CancerOral AlbendazoleOncologyCancer ManagementPharmacologyClinical TrialsPharmacotherapyMaximum Tolerated DoseMetronomic ChemotherapyCancer TreatmentAnti-cancer AgentMedicineChemotherapyCancer Research